Vaccine safety

Publication

Expert opinion on rotavirus vaccination in infancy

expert opinion -

Peer-Reviewed Publication

Immunisation information systems - Useful tools for monitoring vaccination programmes in EU/EEA countries, 2016

2017

Peer-Reviewed Publication

Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines?

2016

Peer-Reviewed Publication

Vaccine hesitancy among healthcare workers in Europe: A qualitative study

2016

Event

Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines

23 Oct 2015
Geneva, Switzerland

Publication

Vaccine hesitancy among healthcare workers and their patients in Europe

technical report -

News

Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2

ECDC comment -

Peer-Reviewed Publication

Safety of human papillomavirus vaccines: A review

2015

Peer-Reviewed Publication

The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines

2015

News

Update on narcolepsy cases associated with Pandemrix vaccination in 2009 in the Netherlands

ECDC comment -

Peer-Reviewed Publication

The roles of influenza virus antigens and the AS03 adjuvant in the 2009 pandemic vaccine associated with narcolepsy needs further investigation

2014

Peer-Reviewed Publication

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: A multinational self-controlled case series in Europe

2014

News

No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix™ Vaccination Campaign in Finland

ECDC comment -

News

New Swedish Registry study confirms increased risk of narcolepsy in children and adolescents after vaccination with Pandemrix

ECDC comment -

News

Association of receipt of Pandemrix™ and narcolepsy in children and adolescents in the UK (England)

ECDC comment -

Peer-Reviewed Publication

Modelling the risk-benefit impact of H1N1 influenza vaccines

2013

Peer-Reviewed Publication

The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns

2013

News

Narcolepsy and Pandemrix Vaccine – an association in adults as well as children

ECDC comment -

Publication

Technical report In Brief: Narcolepsy in association with pandemic influenza vaccination

technical report -

Publication

Narcolepsy in association with pandemic influenza vaccination – a multi-country European epidemiological investigation

technical report -

News

New ECDC technical report on “Narcolepsy in association with pandemic influenza vaccination – a multi-country European epidemiological investigation”

news -

News

Report on the association between the 2009 pandemic vaccine (Pandemrix®) and narcolepsy – Republic of Ireland

ECDC comment -

News

Association of childhood narcolepsy and cataplexy and receipt of a pandemic influenza vaccine in Finland in 2009-10 – First papers in a peer review journal

ECDC comment -

Event

Training workshop on vaccine safety for Member States, building on the experience obtained in the ECDC vaccine safety project VAESCOArchived

23 Feb 2012 - 24 Feb 2012
Stockholm, Sweden

News

Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Pre-Term European Infants: A Randomized Phase IIIb Study

ECDC comment -

Peer-Reviewed Publication

A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark

2012

Peer-Reviewed Publication

Opportunities and challenges of Web 2.0 for vaccination decisions

2012

News

Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine in Children Previously Immunized With 7-valent Pneumococcal Conjugate Vaccine

ECDC comment -

News

Recommendation by the European Medicines Agency concerning Pandemrix vaccination and reports of narcolepsy in children and adolescents

ECDC comment -

News

EMA's Committee for Medicinal Products for Human Use (CHMP) issues opinion on narcolepsy and vaccination with Pandemrix®

news -

News

No association found between pandemic influenza vaccination and Guillain-Barre Syndrome in Europe

ECDC comment -

News

Case inventory study from Sweden concerning association of Pandemrix vaccination and reports of narcolepsy with cataplexy in children and adolescents

ECDC comment -

News

The real issues in vaccine safety

ECDC comment -

News

European Medicines Agency (EMA) 2009 Influenza Pandemic Evaluation

ECDC comment -

News

Narcolepsy following pandemic influenza A H1N1 2009 vaccination - ECDC update: the European Medicines Agency interim measures for Pandemrix

ECDC comment -

News

Swedish MPA publishes interim results of a cohort study assessing the risk of narcolepsy after vaccination with Pandemic influenza vaccine Pandemrix®

ECDC comment -

News

Reports of cases of narcolepsy and cataplexy in children and adolescents in Finland, Iceland, and Sweden

ECDC comment -

News

ECDC – VAESCO investigation into narcolepsy

ECDC comment -

Peer-Reviewed Publication

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: Multinational case-control study in Europe

2011

Peer-Reviewed Publication

Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)

2011

News

Safety experience of influenza vaccination in pregnant women in the US over a 20-year period

ECDC comment -

News

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

ECDC comment -

News

Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom

ECDC comment -

News

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers - Yeh SH et al. Pediatrics 2010; 126(3): e493-e505

ECDC comment -

News

Update of the EMA European Pharmacovigilance Report

ECDC comment -

News

Three 2009 Pandemic Vaccines now on the way to being licensed for use outside the Pandemic

ECDC comment -

News

Vaccine Safety - US Department of Health and Human Services publishes 2009 pandemic influenza A(H1N1) vaccine safety risk assessment

ECDC comment -

News

Vaccine Safety - Update of the EMA’s European Pharmacovigilance Report

ECDC comment -

News

Ninth Update of EMA Pharmacovigilance Report, 3 Feb 2010

ECDC comment -

Peer-Reviewed Publication

Measles still spreads in Europe: Who is responsible for the failure to vaccinate?

2010

Peer-Reviewed Publication

Monitoring and assessing vaccine safety: A European perspective

2010

Peer-Reviewed Publication

Experience and lessons from surveillance and studies of the 2009 pandemic in Europe

2010

Peer-Reviewed Publication

Moderate pandemic, not many dead - Learning the right lessons in Europe from the 2009 pandemic

2010

News

Background rates of disease useful for assessment of pandemic vaccine safety

ECDC comment -

Peer-Reviewed Publication

A Human Case Of Swine Influenza Virus Infection In Europe - Implications For Human Health And Research

2009

Peer-Reviewed Publication

Pandemic influenza A(H1N1) 2009 vaccines in the European Union.

2009

Peer-Reviewed Publication

Assessing vaccines and vaccination programmes in the field

2009

Peer-Reviewed Publication

European Centre for Disease Prevention and Control issues guidance for the introduction of human papillomavirus (HPV) vaccines in European Union countries.

2008

Peer-Reviewed Publication

Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings

2008

Peer-Reviewed Publication

European Immunization Week 2008 - time for reflection.

2008